已发表论文

肝脏缺血/再灌注损伤中的 MAPK 信号通路

 

Authors Yu B, Zhang Y, Wang T, Guo J, Kong C, Chen Z, Ma X, Qiu T

Received 22 November 2022

Accepted for publication 16 March 2023

Published 27 March 2023 Volume 2023:16 Pages 1405—1418

DOI https://doi.org/10.2147/JIR.S396604

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Adam Bachstetter

Abstract: The mitogen-activated protein kinase signaling pathway can be activated by a variety of growth factors, cytokines, and hormones, and mediates numerous intracellular signals related to cellular activities, including cell proliferation, motility, and differentiation. It has been widely studied in the occurrence and development of inflammation and tumor. Hepatic ischemia-reperfusion injury (HIRI) is a common pathophysiological phenomenon that occurs in surgical procedures such as lobectomy and liver transplantation, which is characterized by severe inflammatory reaction after ischemia and reperfusion. In this review, we mainly discuss the role of p38, ERK1/2, JNK in MAPK family and TAK1 and ASK1 in MAPKKK family in HIRI, and try to find an effective treatment for HIRI.
Keywords: ischemia/reperfusion injury, mitogen-activated protein kinases, liver